Kot A, Koszewska D, Ochman B, Swietochowska E
Curr Issues Mol Biol. 2024; 46(12):13811-13845.
PMID: 39727954
PMC: 11727420.
DOI: 10.3390/cimb46120826.
Zhong B, Zhang Y, Zheng H, Chen Q, Lu H, Chen X
Acta Pharmacol Sin. 2024; .
PMID: 39587283
DOI: 10.1038/s41401-024-01418-1.
Liu G, Gao L, Wang Y, Xie X, Gao X, Wu X
Front Cell Dev Biol. 2024; 12:1423665.
PMID: 39364138
PMC: 11447294.
DOI: 10.3389/fcell.2024.1423665.
Didan Y, Ghomlaghi M, Nguyen L, Ng D
Nat Commun. 2024; 15(1):6614.
PMID: 39103333
PMC: 11300869.
DOI: 10.1038/s41467-024-50638-w.
Li L, Zhang G, Yang Z, Kang X
Biomolecules. 2024; 14(4).
PMID: 38672411
PMC: 11047866.
DOI: 10.3390/biom14040393.
The Role of the Dysregulated JNK Signaling Pathway in the Pathogenesis of Human Diseases and Its Potential Therapeutic Strategies: A Comprehensive Review.
Yan H, He L, Lv D, Yang J, Yuan Z
Biomolecules. 2024; 14(2).
PMID: 38397480
PMC: 10887252.
DOI: 10.3390/biom14020243.
Radical pair model for magnetic field effects on NMDA receptor activity.
Nair P, Zadeh-Haghighi H, Simon C
Sci Rep. 2024; 14(1):3628.
PMID: 38351304
PMC: 10864372.
DOI: 10.1038/s41598-024-54343-y.
Insulin signaling and pharmacology in humans and in corals.
Murthy M, Jasbi P, Lowe W, Kumar L, Olaosebikan M, Roger L
PeerJ. 2024; 12:e16804.
PMID: 38313028
PMC: 10838073.
DOI: 10.7717/peerj.16804.
FAT10 is phosphorylated by IKKβ to inhibit the antiviral type-I interferon response.
Saxena K, Roverato N, Reithmann M, Mah M, Schregle R, Schmidtke G
Life Sci Alliance. 2023; 7(1).
PMID: 37940187
PMC: 10631552.
DOI: 10.26508/lsa.202101282.
Arrestin-3-Dependent Activation of c-Jun N-Terminal Kinases (JNKs).
Zhan X, Kaoud T, Dalby K, Gurevich E, Gurevich V
Curr Protoc. 2023; 3(9):e839.
PMID: 37668419
PMC: 10624153.
DOI: 10.1002/cpz1.839.
Neuroprotective Effects of Tryptanthrin-6-Oxime in a Rat Model of Transient Focal Cerebral Ischemia.
Plotnikov M, Chernysheva G, Smolyakova V, Aliev O, Anishchenko A, Ulyakhina O
Pharmaceuticals (Basel). 2023; 16(8).
PMID: 37630972
PMC: 10457995.
DOI: 10.3390/ph16081057.
Genetic deletion of c-Jun amino-terminal kinase 3 (JNK3) modestly increases disease severity in a mouse model of multiple sclerosis.
Priego M, Noriega L, Kalinin S, Hoffman L, Feinstein D, Morfini G
J Neuroimmunol. 2023; 382:578152.
PMID: 37454525
PMC: 10527920.
DOI: 10.1016/j.jneuroim.2023.578152.
Novel Tryptanthrin Derivatives with Selectivity as -Jun N-Terminal Kinase (JNK) 3 Inhibitors.
Schepetkin I, Karpenko O, Kovrizhina A, Kirpotina L, Khlebnikov A, Chekal S
Molecules. 2023; 28(12).
PMID: 37375361
PMC: 10304880.
DOI: 10.3390/molecules28124806.
JNK3 Overexpression in the Entorhinal Cortex Impacts on the Hippocampus and Induces Cognitive Deficiencies and Tau Misfolding.
Ardanaz C, Ezkurdia A, Bejarano A, Echarte B, Smerdou C, Martisova E
ACS Chem Neurosci. 2023; 14(11):2074-2088.
PMID: 37236204
PMC: 10251484.
DOI: 10.1021/acschemneuro.3c00092.
Cardioprotective Effects of a Selective c-Jun N-terminal Kinase Inhibitor in a Rat Model of Myocardial Infarction.
Plotnikov M, Chernysheva G, Smolyakova V, Aliev O, Fomina T, Sandrikina L
Biomedicines. 2023; 11(3).
PMID: 36979693
PMC: 10044897.
DOI: 10.3390/biomedicines11030714.
Changes in TFG gene expression in bovine leucocytes transformed by .
Zhao H, Li X, Liu J, Guan G, Luo J
Front Vet Sci. 2022; 9:997294.
PMID: 36337204
PMC: 9630592.
DOI: 10.3389/fvets.2022.997294.
Phosphorylation of RXRα mediates the effect of JNK to suppress hepatic FGF21 expression and promote metabolic syndrome.
Vernia S, Lee A, Kennedy N, Han M, Isasa M, Cavanagh-Kyros J
Proc Natl Acad Sci U S A. 2022; 119(44):e2210434119.
PMID: 36282921
PMC: 9636906.
DOI: 10.1073/pnas.2210434119.
Radiolabeled Aminopyrazoles as Novel Isoform Selective Probes for pJNK3 Quantification.
Bales B, Cotero V, Meyer D, Roberts J, Rodriguez-Silva M, Siclovan T
ACS Med Chem Lett. 2022; 13(10):1606-1614.
PMID: 36262398
PMC: 9575163.
DOI: 10.1021/acsmedchemlett.2c00278.
Keratocyte Differentiation Is Regulated by NF-κB and TGFβ Signaling Crosstalk.
Zhou X, Li J, Backman L, Danielson P
Int J Mol Sci. 2022; 23(19).
PMID: 36232373
PMC: 9570283.
DOI: 10.3390/ijms231911073.
MAPK Signaling Pathway in Oral Squamous Cell Carcinoma: Biological Function and Targeted Therapy.
Cheng Y, Chen J, Shi Y, Fang X, Tang Z
Cancers (Basel). 2022; 14(19).
PMID: 36230547
PMC: 9563402.
DOI: 10.3390/cancers14194625.